Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.21 USD
Change Today +0.03 / 1.38%
Volume 900.1K
SNTA On Other Exchanges
Symbol
Exchange
Stuttgart
As of 8:10 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Safi R. Bahcall Ph.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

46--
As of Fiscal Year 2014

Background*

Dr. Safi R. Bahcall serves as an Advisor of SCIUS Capital Group, Investment Arm. Mr. Bahcall founded and served as the Chief Executive Officer of Synta Pharmaceuticals Corp. since July 2001 until March 03, 2014. Mr. Bahcall served as the President of Synta Pharmaceuticals Corp. since December 2003 until March 03, 2014. Mr. Bahcall was a Consultant at McKinsey & Co. with more than 15 years experience. Mr. Bahcall served as a Director of Synta Pharmaceuticals Corp. since ...

Read Full Background

Corporate Headquarters*

45 Hartwell Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-274-8200
Fax: 781-274-8228

Board Members Memberships*

2001-2014
Co-Founder

Education*

BA
Harvard University
PhD
Stanford University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNTA:US $2.21 USD +0.03

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNTA PHARMACEUTICALS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.